| The first century of cancer chemotherapy |
| S Hellman |
|
JCO Jul 1 1998: 2295–2296.
[PDF]
|
 |
| Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit? |
| MJ Ratain |
|
JCO Jul 1 1998: 2297–2298.
[PDF]
|
|
|
Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation |
| |
HP Gurney, S Ackland, V Gebski, and G Farrell |
| |
JCO Jul 1 1998: 2299–2304.
[Abstract]
[PDF]
|
|
|
Study of cohort-specific consent and patient control in phase I cancer trials |
| |
CK Daugherty, MJ Ratain, H Minami, DM Banik, NJ Vogelzang, WM Stadler, and M Siegler |
| |
JCO Jul 1 1998: 2305–2312.
[Abstract]
[PDF]
|
|
|
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia |
| |
BD Cheson, JN Frame, D Vena, N Quashu, and JM Sorensen |
| |
JCO Jul 1 1998: 2313–2320.
[Abstract]
[PDF]
|
|
|
Cellular pharmacodynamics and plasma pharmacokinetics of parenterally infused hydroxyurea during a phase I clinical trial in chronic myelogenous leukemia |
| |
V Gandhi, W Plunkett, H Kantarjian, M Talpaz, LE Robertson, and S O'Brien |
| |
JCO Jul 1 1998: 2321–2331.
[Abstract]
[PDF]
|
|
|
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial |
| |
P Solal-Celigny, E Lepage, N Brousse, CL Tendler, P Brice, C Haioun, J Gabarre, B Pignon, G Tertian, R Bouabdallah, JF Rossi, C Doyen, and B Coiffier |
| |
JCO Jul 1 1998: 2332–2338.
[Abstract]
[PDF]
|
|
|
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making |
| |
BF Cole, P Solal-Celigny, RD Gelber, E Lepage, C Gisselbrecht, F Reyes, C Sebban, D Sugano, C Tendler, and A Goldhirsch |
| |
JCO Jul 1 1998: 2339–2344.
[Abstract]
[PDF]
|
|
|
Phase II and dose-escalation with or without granulocyte colony- stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas [published erratum appears in J Clin Oncol 1998 Aug;16(8):2895] |
| |
WH Wilson, R Little, D Pearson, ES Jaffe, SM Steinberg, BD Cheson, R Humphrey, DR Kohler, and P Elwood |
| |
JCO Jul 1 1998: 2345–2351.
[Abstract]
[PDF]
|
|
|
Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity |
| |
H Gomez, L Mas, L Casanova, DL Pen, S Santillana, S Valdivia, J Otero, W Rodriguez, C Carracedo, and C Vallejos |
| |
JCO Jul 1 1998: 2352–2358.
[Abstract]
[PDF]
|
|
|
Ovarian function after autologous bone marrow transplantation |
| |
AD Schimmer, M Quatermain, K Imrie, V Ali, J McCrae, AK Stewart, M Crump, C Derzko, and A Keating |
| |
JCO Jul 1 1998: 2359–2363.
[Abstract]
[PDF]
|
|
|
Costs of blood transfusion: a process-flow analysis |
| |
SB Cantor, DV Hudson, Jr, B Lichtiger, and EB Rubenstein |
| |
JCO Jul 1 1998: 2364–2370.
[Abstract]
[PDF]
|
|
|
Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen |
| |
M Colleoni, G Martinelli, F Beretta, C Marone, A Gallino, M Fontana, R Graffeo, G Zampino, T De Pas, G Cipolla, C Martinoni, and A Goldhirsch |
| |
JCO Jul 1 1998: 2371–2376.
[Abstract]
[PDF]
|
|
|
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors |
| |
CL Loprinzi, TM Pisansky, R Fonseca, JA Sloan, KM Zahasky, SK Quella, PJ Novotny, TA Rummans, DA Dumesic, and EA Perez |
| |
JCO Jul 1 1998: 2377–2381.
[Abstract]
[PDF]
|
|
|
Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor- negative breast cancer: an Intergroup study |
| |
JH Fetting, R Gray, DL Fairclough, TJ Smith, KA Margolin, ML Citron, M Grove- Conrad, D Cella, K Pandya, N Robert, IC Henderson, CK Osborne, and MD Abeloff |
| |
JCO Jul 1 1998: 2382–2391.
[Abstract]
[PDF]
|
|
|
First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy |
| |
JH Silber, M Fridman, RS DiPaola, MH Erder, MV Pauly, and KR Fox |
| |
JCO Jul 1 1998: 2392–2400.
[Abstract]
[PDF]
|
|
|
Construction and validation of a practical prognostic index for patients with metastatic breast cancer |
| |
N Yamamoto, T Watanabe, N Katsumata, Y Omuro, M Ando, H Fukuda, Y Takue, M Narabayashi, I Adachi, and S Takashima |
| |
JCO Jul 1 1998: 2401–2408.
[Abstract]
[PDF]
|
|
|
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy |
| |
RR Mehta, JH McDermott, TJ Hieken, KC Marler, MK Patel, LD Wild, and TK Das Gupta |
| |
JCO Jul 1 1998: 2409–2416.
[Abstract]
[PDF]
|
|
|
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk |
| |
TS Frank, SA Manley, OI Olopade, S Cummings, JE Garber, B Bernhardt, K Antman, D Russo, ME Wood, L Mullineau, C Isaacs, B Peshkin, S Buys, V Venne, PT Rowley, S Loader, K Offit, M Robson, H Hampel, D Brener, EP Winer, S Clark, B Weber, LC Strong, and A Thomas |
| |
JCO Jul 1 1998: 2417–2425.
[Abstract]
[PDF]
|
|
|
Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group |
| |
M Gore, P Mainwaring, R A'Hern, V MacFarlane, M Slevin, P Harper, R Osborne, J Mansi, P Blake, E Wiltshaw, and J Shepherd |
| |
JCO Jul 1 1998: 2426–2434.
[Abstract]
[PDF]
|
|
|
Modeling the cost-effectiveness of granulocyte colony-stimulating factor use in early-stage breast cancer |
| |
JH Silber, M Fridman, A Shpilsky, O Even-Shoshan, DS Smink, J Jayaraman, KR Fox, and MV Pauly |
| |
JCO Jul 1 1998: 2435–2444.
[Abstract]
[PDF]
|
|
|
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial |
| |
DW Northfelt, BJ Dezube, JA Thommes, BJ Miller, MA Fischl, A Friedman-Kien, LD Kaplan, C Du Mond, RD Mamelok, and DH Henry |
| |
JCO Jul 1 1998: 2445–2451.
[Abstract]
[PDF]
|
|
|
Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol |
| |
PA Meyers, R Gorlick, G Heller, E Casper, J Lane, AG Huvos, and JH Healey |
| |
JCO Jul 1 1998: 2452–2458.
[Abstract]
[PDF]
|
|
|
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study |
| |
AJ Wozniak, JJ Crowley, SP Balcerzak, GR Weiss, CH Spiridonidis, LH Baker, KS Albain, K Kelly, SA Taylor, DR Gandara, and RB Livingston |
| |
JCO Jul 1 1998: 2459–2465.
[Abstract]
[PDF]
|
|
|
Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083 |
| |
MC Perry, JE Herndon, 3rd, WL Eaton, and MR Green |
| |
JCO Jul 1 1998: 2466–2467.
[Abstract]
[PDF]
|
|
|
Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications |
| |
DJ Kwiatkowski, DH Harpole, Jr, J Godleski, JE Herndon, 2nd, DB Shieh, W Richards, R Blanco, HJ Xu, GM Strauss, and DJ Sugarbaker |
| |
JCO Jul 1 1998: 2468–2477.
[Abstract]
[PDF]
|
|
|
Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome |
| |
WG Scheurlen, GC Schwabe, S Joos, J Mollenhauer, N Sorensen, and J Kuhl |
| |
JCO Jul 1 1998: 2478–2485.
[Abstract]
[PDF]
|
|
|
Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors |
| |
S Guruangan, IJ Dunkel, S Goldman, JH Garvin, M Rosenblum, JM Boyett, S Gardner, TE Merchant, S Gollamudi, and JL Finlay |
| |
JCO Jul 1 1998: 2486–2493.
[Abstract]
[PDF]
|
|
|
Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study |
| |
AM Langevin, DT Casto, PJ Thomas, SD Weitman, C Kretschmar, H Grier, C Pratt, R Dubowy, M Bernstein, S Blaney, and T Vietti |
| |
JCO Jul 1 1998: 2494–2499.
[Abstract]
[PDF]
|
|
|
Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor |
| |
Sr Loehrer PJ, R Gonin, CR Nichols, T Weathers, and LH Einhorn |
| |
JCO Jul 1 1998: 2500–2504.
[Abstract]
[PDF]
|
|
|
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group |
| |
JM Tourani, C Pfister, JF Berdah, A Benhammouda, P Salze, A Monnier, B Paule, P Guillet, Y Chretien, Y Brewer, M Di Palma, M Untereiner, E Malaurie, Z Tadrist, JM Pavlovitch, D Hauteville, A Mejean, M Azagury, D Mayeur, V Lucas, I Krakowski, D Larregain-Fournier, H Abourachid, JM Andrieu, and C Chastang |
| |
JCO Jul 1 1998: 2505–2513.
[Abstract]
[PDF]
|
|
|
Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx |
| |
LL Siu, PM Czaykowski, and IF Tannock |
| |
JCO Jul 1 1998: 2514–2521.
[Abstract]
[PDF]
|
|
|
Methylphenidate therapy improves cognition, mood, and function of brain tumor patients |
| |
CA Meyers, MA Weitzner, AD Valentine, and VA Levin |
| |
JCO Jul 1 1998: 2522–2527.
[Abstract]
[PDF]
|
|
|
Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver |
| |
MJ O'Connell, DM Nagorney, AM Bernath, G Schroeder, RJ Fitzgibbons, JA Mailliard, P Burch, JS Bolton, G Colon-Otero, and JE Krook |
| |
JCO Jul 1 1998: 2528–2533.
[Abstract]
[PDF]
|
|
|
Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors |
| |
H Orlefors, A Sundin, H Ahlstrom, P Bjurling, M Bergstrom, A Lilja, B Langstrom, K Oberg, and B Eriksson |
| |
JCO Jul 1 1998: 2534–2541.
[Abstract]
[PDF]
|
|
|
Radiation therapy for rectosigmoid and rectal cancer: results of the 1992-1994 Patterns of Care process survey |
| |
BD Minsky, L Coia, DG Haller, J Hoffman, M John, J Landry, TM Pisansky, C Willett, I Mahon, J Owen, B Berkey, A Katz, and G Hanks |
| |
JCO Jul 1 1998: 2542–2547.
[Abstract]
[PDF]
|
|
|
Cancer gene therapy: connecting basic research with clinical inquiry |
| |
G Dranoff |
| |
JCO Jul 1 1998: 2548–2556.
[Abstract]
[PDF]
|
|
|
Oral chemotherapy: rationale and future directions |
| |
MD DeMario and MJ Ratain |
| |
JCO Jul 1 1998: 2557–2567.
[Abstract]
[PDF]
|
|
| Diagnosis in oncology. Mantle-cell lymphoma |
| J Chen, SH Swerdlow, and SA Jacobs |
|
JCO Jul 1 1998: 2568–2569.
[PDF]
|
|
| Ethics of randomized clinical trials |
| PM Ellis and AS Coates |
|
JCO Jul 1 1998: 2570a.
[PDF]
|
|
| Second cancers after pediatric Hodgkin's disease |
| S Bhatia, AT Meadows, and LL Robison |
|
JCO Jul 1 1998: 2570b–2572.
[PDF]
|
|
| Long-term pamidronate in multiple myeloma |
| JF Seymour |
|
JCO Jul 1 1998: 2572–2573.
[PDF]
|
|
| Prognosis of tamoxifen-associated endometrial cancer |
| C Lasset, H Mignotte, V Bonadona, and F Chauvin |
|
JCO Jul 1 1998: 2573a.
[PDF]
|
|
| Breast and ovarian cancer prone women and prophylactic surgery temptation |
| F Eisinger, C Julian-Reynier, D Stoppa-Lyonnet, P Vennin, C Lasset, C Nogues, and H Sobol |
|
JCO Jul 1 1998: 2573b–2575.
[PDF]
|
|
